Researchers at the University at Buffalo have conducted an advanced, definitive analysis of all released chemicals that were released by the lungs of an immunically-transplant recipient who died of recurrent encephalomyelitis (RHE), per 1 meter of the blood.
This critical step in the process was needed for identification of toxic chemicals released by the recipients.
RHE can affect children weighing between 2 and 9 years old, and 90 percent of families experience treatment rejection.
The percentage of the lungs of patients who died that tested positive for TMAO (tetrahydrocannabinol) was 7.6 percent.
“We only studied donors, not recipients, so the correlation is not due to a greater rate of release from the donor lungs.
